Sp188

PROGNOSTICATION OF DISEASE COURSE IN IBD: THE PRESENT AND THE FUTURE

Date
May 18, 2024
Explore related products in the following collection:

Presenter

Speaker Image for Séverine Vermeire
Katholieke Universiteit Leuven Universitaire Ziekenhuizen Leuven

Tracks

Related Products

Thumbnail for FAECAL MICROBIOTA TRANSPLANTATION IN ACTIVE ULCERATIVE COLITIS: INSIGHTS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY
FAECAL MICROBIOTA TRANSPLANTATION IN ACTIVE ULCERATIVE COLITIS: INSIGHTS FROM A RANDOMIZED CONTROLLED TRIAL HALTED FOR FUTILITY
INTRO/BACKGROUND Rigorous donor preselection on microbiota level, strict anaerobic processing, and repeated FMT administration were hypothesized to improve FMT outcomes for induction of remission in UC in the RESTORE-UC trial, for which we here report on the clinical results and observed microbial…
Thumbnail for THE EFFECT OF NLRX1 ACTIVATION ON EOSINOPHILS IN ULCERATIVE COLITIS AND INFLAMMATION: TRANSLATIONAL LEARNINGS ACROSS DISEASES AND FROM MOUSE TO HUMAN
THE EFFECT OF NLRX1 ACTIVATION ON EOSINOPHILS IN ULCERATIVE COLITIS AND INFLAMMATION: TRANSLATIONAL LEARNINGS ACROSS DISEASES AND FROM MOUSE TO HUMAN
Background: Although the precise role of eosinophils in IBD is debated, elevated eosinophils may influence response to therapy and clinical outcomes1. Thus, therapeutic agents which affect both neutrophil and eosinophil recruitment may provide more robust clinical improvement in patients with UC…
Thumbnail for EFFICACY AND SAFETY OF OBEFAZIMOD IN UC PATIENTS AT WEEKS 48 AND 96 OF AN OPEN-LABEL MAINTENANCE STUDY AMONG CLINICAL RESPONDERS AT WEEK 8 OF THE PHASE 2B INDUCTION TRIAL
EFFICACY AND SAFETY OF OBEFAZIMOD IN UC PATIENTS AT WEEKS 48 AND 96 OF AN OPEN-LABEL MAINTENANCE STUDY AMONG CLINICAL RESPONDERS AT WEEK 8 OF THE PHASE 2B INDUCTION TRIAL
Obefazimod is an investigational, oral, once-daily, small molecule which enhances expression of microRNA-124 and is currently in phase 3 clinical trials for the treatment of patients with moderately to severely active ulcerative colitis (UC) [1]…